These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. Bidet M; Bellanné-Chantelot C; Galand-Portier MB; Tardy V; Billaud L; Laborde K; Coussieu C; Morel Y; Vaury C; Golmard JL; Claustre A; Mornet E; Chakhtoura Z; Mowszowicz I; Bachelot A; Touraine P; Kuttenn F J Clin Endocrinol Metab; 2009 May; 94(5):1570-8. PubMed ID: 19208730 [TBL] [Abstract][Full Text] [Related]
6. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene. Livadas S; Dracopoulou M; Dastamani A; Sertedaki A; Maniati-Christidi M; Magiakou AM; Kanaka-Gantenbein C; Chrousos GP; Dacou-Voutetakis C Clin Endocrinol (Oxf); 2015 Apr; 82(4):543-9. PubMed ID: 25041270 [TBL] [Abstract][Full Text] [Related]
7. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone. Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851 [TBL] [Abstract][Full Text] [Related]
8. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome. Pignatelli D Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412 [TBL] [Abstract][Full Text] [Related]
9. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype. Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666 [TBL] [Abstract][Full Text] [Related]
10. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751 [TBL] [Abstract][Full Text] [Related]
11. CYP21A2 genotypes do not predict the severity of hyperandrogenic manifestations in the nonclassical form of congenital adrenal hyperplasia. Moura-Massari VO; Bugano DD; Marcondes JA; Gomes LG; Mendonca BB; Bachega TA Horm Metab Res; 2013 Apr; 45(4):301-7. PubMed ID: 23322511 [TBL] [Abstract][Full Text] [Related]
12. Results of the ACTH stimulation test in hirsute women. Erel CT; Senturk LM; Oral E; Mutlu H; Colgar U; Seyisoglu H; Ertungealp E J Reprod Med; 1999 Mar; 44(3):247-52. PubMed ID: 10202742 [TBL] [Abstract][Full Text] [Related]
13. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Escobar-Morreale HF; San Millán JL; Smith RR; Sancho J; Witchel SF Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100 [TBL] [Abstract][Full Text] [Related]
14. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency. Speiser PW; New MI J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431 [TBL] [Abstract][Full Text] [Related]
15. Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients. Dain LB; Buzzalino ND; Oneto A; Belli S; Stivel M; Pasqualini T; Minutolo C; Charreau EH; Alba LG Clin Endocrinol (Oxf); 2002 Feb; 56(2):239-45. PubMed ID: 11874416 [TBL] [Abstract][Full Text] [Related]
17. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. Krone N; Braun A; Roscher AA; Knorr D; Schwarz HP J Clin Endocrinol Metab; 2000 Mar; 85(3):1059-65. PubMed ID: 10720040 [TBL] [Abstract][Full Text] [Related]
18. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency. Menassa R; Tardy V; Despert F; Bouvattier-Morel C; Brossier JP; Cartigny M; Morel Y J Clin Endocrinol Metab; 2008 May; 93(5):1901-8. PubMed ID: 18319307 [TBL] [Abstract][Full Text] [Related]
19. The prevalence of non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Russian women with hyperandrogenism. Grodnitskaya E; Kurtser M Hum Fertil (Camb); 2018 Dec; 21(4):281-287. PubMed ID: 28669219 [TBL] [Abstract][Full Text] [Related]
20. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations. Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]